Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Ty Collin
CIBC

Ty Collin

Wall Street Analyst
β˜…β˜…β˜…β˜…β˜†
#518
on 13Foresight Β· ranked by our own returns
60%
Success Rate
+4.3%
Average Return
21 of 35 calls profitable Β· +3.4% vs benchmark
S&P 500 (SPY)
πŸ“ˆ Across the calls we could measure, roughly 60% of Ty Collin's ratings turned a profit when each position was held for 1 year β€” averaging +4.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

33 Buy 16 Hold 0 Sell
Ty's Stock Coverage 13 ratings Β· 2026-11-19
Company Date Position Consensus β“˜ Price Target β“˜ 1-Yr Return vs S&P 500 β“˜
TSE:TOY
Spin Master
Oct 30, 2026 HOLD Strong Buy
+52.9% avg upside
13 analysts
$23.00
12.53% Upside
+8.4% Β·
TSE:NFI
NFI Group Inc
Oct 26, 2026 BUY Strong Buy
+18.8% avg upside
9 analysts
$30.00
23.02% Upside
-2.8% Β·
TSE:LNF
Leon's Furniture
Oct 26, 2026 HOLD Buy
+8.3% avg upside
4 analysts
$26.00
0.76% Downside
+4.0% Β·
TSE:LNR
Linamar
Oct 21, 2026 BUY Strong Buy
+11.1% avg upside
9 analysts
$110.00
24.21% Upside
-3.3% Β·
TSE:MG
Magna International
Oct 21, 2026 HOLD Buy
-0.9% avg upside
31 analysts
$97.83
10.07% Upside
-1.3% Β·
TSE:MRE
Martinrea International
Oct 21, 2026 BUY Buy
+53.2% avg upside
8 analysts
$12.00
26.89% Upside
+18.9% Β·
TSE:PBH
Premium Brands
Oct 16, 2026 BUY Strong Buy
+47.1% avg upside
13 analysts
$94.00
28.84% Upside
+9.7% Β·
TSE:MFI
Maple Leaf Foods
Oct 16, 2026 BUY Strong Buy
+33.0% avg upside
11 analysts
$32.00
18.20% Upside
+7.5% Β·
TSE:PET
Pet Valu Holdings Ltd.
Oct 07, 2026 BUY Strong Buy
+31.8% avg upside
10 analysts
$22.00
10.19% Upside
+25.6% Β·
TSE:NWC
North West
Sep 10, 2026 BUY Strong Buy
-6.3% avg upside
7 analysts
$62.00
8.76% Upside
+15.0% Β·
TSE:DIV
Diversified Royalty Corp
Aug 14, 2026 HOLD Buy
+9.7% avg upside
7 analysts
$4.40
7.80% Upside
-13.2% Β·
TSE:ACQ
AutoCanada
Aug 14, 2026 HOLD Hold
-16.7% avg upside
12 analysts
$26.00
8.41% Downside
+13.2% Β·
TSE:JWEL
Jamieson Wellness Inc
May 08, 2026 BUY Strong Buy
-9.4% avg upside
11 analysts
$44.00
3.52% Downside
+31.4% Β·
πŸ”’ 8 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ty Collin β€” Frequently Asked Questions
How accurate are Ty Collin's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Ty's ratings were profitable over a one-year hold, with an average return of +4.3% per rating, or +3.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ty ranked on 13Foresight?
Ty Collin is currently ranked #518 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ty cover?
Ty most recently has ratings on TSE:TOY, TSE:NFI, TSE:LNF, TSE:LNR, TSE:MG, TSE:MRE, TSE:PBH, TSE:MFI, TSE:PET, TSE:NWC, TSE:DIV, TSE:ACQ and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.